Cargando…
Zeolitic Imidazolate Framework‐8 as pH‐Sensitive Nanocarrier for “Arsenic Trioxide” Drug Delivery
Previous results revealed that arsenic trioxide might be used as promising therapeutic agent for the treatment of some solid tumours as atypical teratoid rhabdoid tumours (ATRT). However, in order to become an approved drug for solid tumour treatment, the active formulation has to get more efficient...
Autores principales: | Ettlinger, Romy, Moreno, Natalia, Volkmer, Dirk, Kerl, Kornelius, Bunzen, Hana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856809/ https://www.ncbi.nlm.nih.gov/pubmed/31336004 http://dx.doi.org/10.1002/chem.201902599 |
Ejemplares similares
-
ATRT-15. LY6D – A CANDIDATE FOR NANOPARTICLE-BASED TARGETED THERAPIES OF ATRT
por: Hagemeier, Lea, et al.
Publicado: (2020) -
Long-term entrapment and temperature-controlled-release of SF(6) gas in metal–organic frameworks (MOFs)
por: Bunzen, Hana, et al.
Publicado: (2019) -
Reversed Crystal Growth of RHO Zeolitic Imidazolate Framework (ZIF)
por: Self, Katherine, et al.
Publicado: (2015) -
Vibrational Fingerprinting of Defects Sites in Thin Films of Zeolitic Imidazolate Frameworks
por: Weckhuysen, Bert M., et al.
Publicado: (2019) -
Tailored Mobility in a Zeolite Imidazolate Framework (ZIF) Antibody Conjugate
por: Chapartegui‐Arias, Ander, et al.
Publicado: (2021)